Literature DB >> 14655760

Molecular changes in normal appearing white matter in multiple sclerosis are characteristic of neuroprotective mechanisms against hypoxic insult.

Ursula Graumann1, Richard Reynolds, Andreas J Steck, Nicole Schaeren-Wiemers.   

Abstract

Multiple sclerosis is a chronic inflammatory disease of the CNS leading to focal destruction of myelin, still the earliest changes that lead to lesion formation are not known. We have studied the gene-expression pattern of 12 samples of normal appearing white matter from 10 post-mortem MS brains. Microarray analysis revealed upregulation of genes involved in maintenance of cellular homeostasis, and in neural protective mechanisms known to be induced upon ischemic preconditioning. This is best illustrated by the upregulation of the transcription factors such as HIF-1alpha and associated PI3K/Akt signalling pathways, as well as the upregulation of their target genes such as VEGF receptor 1. In addition, a general neuroprotective reaction against oxidative stress is suggested. These molecular changes might reflect an adaptation of cells to the chronic progressive pathophysiology of MS. Alternatively, they might also indicate the activation of neural protective mechanisms allowing preservation of cellular and functional properties of the CNS. Our data introduce novel concepts of the molecular pathogenesis of MS with ischemic preconditioning as a major mechanism for neuroprotection. An increased understanding of the underlying mechanisms may lead to the development of new more specific treatment to protect resident cells and thus minimize progressive oligondendrocyte and axonal loss.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14655760      PMCID: PMC8096038          DOI: 10.1111/j.1750-3639.2003.tb00485.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  45 in total

Review 1.  The late phase of preconditioning.

Authors:  R Bolli
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

Review 2.  p21-activated kinases: three more join the Pak.

Authors:  Zahara M Jaffer; Jonathan Chernoff
Journal:  Int J Biochem Cell Biol       Date:  2002-07       Impact factor: 5.085

3.  Preferential loss of myelin-associated glycoprotein reflects hypoxia-like white matter damage in stroke and inflammatory brain diseases.

Authors:  Fahmy Aboul-Enein; Helmut Rauschka; Barbara Kornek; Christine Stadelmann; Andreas Stefferl; Wolfgang Brück; Claudia Lucchinetti; Manfred Schmidbauer; Kurt Jellinger; Hans Lassmann
Journal:  J Neuropathol Exp Neurol       Date:  2003-01       Impact factor: 3.685

4.  Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery.

Authors:  S R Datta; H Dudek; X Tao; S Masters; H Fu; Y Gotoh; M E Greenberg
Journal:  Cell       Date:  1997-10-17       Impact factor: 41.582

Review 5.  Critical role for nitric oxide signaling in cardiac and neuronal ischemic preconditioning and tolerance.

Authors:  K Nandagopal; T M Dawson; V L Dawson
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

6.  Requirement for nitric oxide activation of p21(ras)/extracellular regulated kinase in neuronal ischemic preconditioning.

Authors:  M Gonzalez-Zulueta; A B Feldman; L J Klesse; R G Kalb; J F Dillman; L F Parada; T M Dawson; V L Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 7.  Integration of calcium and Ras signalling.

Authors:  Peter J Cullen; Peter J Lockyer
Journal:  Nat Rev Mol Cell Biol       Date:  2002-05       Impact factor: 94.444

Review 8.  Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology.

Authors:  G L Semenza
Journal:  Trends Mol Med       Date:  2001-08       Impact factor: 11.951

Review 9.  HIF-1 and tumor progression: pathophysiology and therapeutics.

Authors:  Gregg L Semenza
Journal:  Trends Mol Med       Date:  2002       Impact factor: 11.951

10.  Hypoxia enhances the expression of autocrine motility factor and the motility of human pancreatic cancer cells.

Authors:  H Niizeki; M Kobayashi; I Horiuchi; N Akakura; J Chen; J Wang; J-i Hamada; P Seth; H Katoh; H Watanabe; A Raz; M Hosokawa
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more
  73 in total

1.  Comparative gene expression analysis in mouse models for multiple sclerosis, Alzheimer's disease and stroke for identifying commonly regulated and disease-specific gene changes.

Authors:  Vivian Tseveleki; Renee Rubio; Sotiris-Spyros Vamvakas; Joseph White; Era Taoufik; Edwige Petit; John Quackenbush; Lesley Probert
Journal:  Genomics       Date:  2010-05-07       Impact factor: 5.736

Review 2.  Gene expression profiling in neurological disorders: toward a systems-level understanding of the brain.

Authors:  Sergio E Baranzini
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 3.  Genomics and proteomics: role in the management of multiple sclerosis.

Authors:  Ludwig Kappos; Lutz Achtnichts; Frank Dahlke; Jens Kuhle; Y Naegelin; Rupert Sandbrink; Raija L P Lindberg
Journal:  J Neurol       Date:  2005-09       Impact factor: 4.849

4.  Normal-appearing white matter permeability distinguishes poor cognitive performance in processing speed and working memory.

Authors:  A Eilaghi; A Kassner; I Sitartchouk; P L Francis; R Jakubovic; A Feinstein; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2013-05-30       Impact factor: 3.825

5.  Glatiramer acetate treatment normalized the monocyte activation profile in MS patients to that of healthy controls.

Authors:  Delgertsetseg Chuluundorj; Scott A Harding; David Abernethy; Anne Camille La Flamme
Journal:  Immunol Cell Biol       Date:  2016-10-03       Impact factor: 5.126

Review 6.  The pathological spectrum of CNS inflammatory demyelinating diseases.

Authors:  Wei Hu; Claudia F Lucchinetti
Journal:  Semin Immunopathol       Date:  2009-09-25       Impact factor: 9.623

7.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.

Authors:  Andrew W Varga; Glyn Johnson; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2009-01-31       Impact factor: 3.181

8.  Endogenous erythropoietin as part of the cytokine network in the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Manuela Mengozzi; Ilaria Cervellini; Paolo Bigini; Sara Martone; Antonella Biondi; Rosetta Pedotti; Barbara Gallo; Sara Barbera; Tiziana Mennini; Mariaserena Boraso; Marina Marinovich; Edwige Petit; Myriam Bernaudin; Roberto Bianchi; Barbara Viviani; Pietro Ghezzi
Journal:  Mol Med       Date:  2008-07-30       Impact factor: 6.354

Review 9.  Is multiple sclerosis a mitochondrial disease?

Authors:  Peizhong Mao; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2009-07-14

10.  Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures.

Authors:  Robert P Lisak; Joyce A Benjamins; Beverly Bealmear; Liljana Nedelkoska; Diane Studzinski; Ernest Retland; Bin Yao; Susan Land
Journal:  J Neuroinflammation       Date:  2009-01-21       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.